Lazard Asset Management
LUNG icon

Lazard Asset Management’s Pulmonx LUNG Stock Holding History

Lazard Asset Management’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.4K Hold
14,156
– – ﹤0.01% 1859
2026
Q1 		$18.3K Hold
14,156
– – ﹤0.01% 1809
2025
Q4 		$31.3K Buy
+14,156
New +$26.6K ﹤0.01% 1813
2025
Q3 		– Sell
-2,144
Closed -$5K – 2107
2025
Q2 		$5K Sell
2,144
-95,515
-98% -$377K ﹤0.01% 2198
2025
Q1 		$657K Buy
97,659
+87,663
+877% +$621K ﹤0.01% 1336
2024
Q4 		$67K Buy
9,996
+264
+3% +$1.74K ﹤0.01% 1916
2024
Q3 		$80K Buy
+9,732
New +$70.4K ﹤0.01% 1824

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ECM
ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $417M AUM 22.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Lazard Asset Management's LUNG Position: Q2 2026 in Review

Lazard Asset Management held its Pulmonx (LUNG) position steady in Q2 2026 at 14,156 shares worth $18.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1859.

Lazard Asset Management first reported a position in LUNG in Q3 2024 and has held it in 7 quarters since. The position peaked at $657K in Q1 2025. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Lazard Asset Management held 14,156 shares of Pulmonx worth $18.4K as of Q2 2026.
  • Lazard Asset Management left its Pulmonx share count unchanged in Q2 2026.
  • Pulmonx made up ﹤0.01% of Lazard Asset Management's portfolio in Q2 2026, its #1859 holding.
  • Lazard Asset Management first reported a position in Pulmonx in Q3 2024 and has held it in 7 quarters since.
  • Lazard Asset Management's Pulmonx position peaked at $657K in Q1 2025.
  • 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Lazard Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.